MedPath

DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents. A prospective, randomized, controlled, triple-blind, multi-center trial comparing PTFE-covered balloon-expandable stents versus uncovered balloon-expandable stents in patients with advanced occlusive disease of the common iliac artery in terms of morphologic, clinical, and hemodynamic outcome after a 2-year follow-up.

Completed
Conditions
arteriosclerosis of the leg
Peripheral Arterial Occlusive Disease (PAOD)
10003216
Registration Number
NL-OMON41499
Lead Sponsor
Maasstadziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
174
Inclusion Criteria

- Age over 18
- Symptomatic, atherosclerotic lesion of the common iliac artery, either a hemodynamically significant stenosis with a length of more than 3 cm, or an occlusion
- Signed informed consent form

Exclusion Criteria

- Stenosis with a length of less than 3 cm
- Presence of a metastatic malignancy, or other disease that limits life expectancy to less than two years.
- Previous endovascular or surgical treatment of the common iliac artery on the affected side.
- Inability or unwillingness to comply with the follow-up schedule.
- Mental disability or language barrier that hinders the ability to understand and comply with the informed consent.
- Pregnancy or breast-feeding.
- Severe renal failure (e-GFR <30 mL/min/1.73 m2)
- Known allergy to iodinated contrast agents or to PTFE.
- Contra-indication for anti-coagulation.
- Acute limb ischemia
- Occlusion of the abdominal aorta
- Aneurysm of the abdominal aorta that is not amenable to endograft placement

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.